Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival
about
Systemic sclerosis: commonly asked questions by rheumatologistsN-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control studyRecommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertensionApplication of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre.High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis: application in a single center.Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registryAn official American Thoracic Society Statement: pulmonary hypertension phenotypesBorderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT studyConnective tissue disease-associated pulmonary arterial hypertension.A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosisValue of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.Biomarkers of pulmonary hypertension in patients with scleroderma: a case-control study.Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease.Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature.Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era.Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normals--a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changes.Exhaled nitric oxide in pulmonary arterial hypertension associated with systemic sclerosisPrevalence of Pulmonary Arterial Hypertension in Korean Adult Patients with Systemic Sclerosis: Result of a Pilot Echocardiographic Screening Study.Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme.The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.Update in pulmonary vascular diseases 2011.Systemic sclerosis--challenges for clinical practice.Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis.Performance of screening algorithms in systemic sclerosis-related pulmonary arterial hypertension: a systematic review.Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis.Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review.Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development.Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.Early detection of pulmonary arterial hypertension.Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension.Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).Biomarkers in Scleroderma: Progressing from Association to Clinical Utility.Pulmonary hypertension in connective tissue diseases: an update.Reference ranges and determinants of right ventricle outflow tract acceleration time in healthy adults by two-dimensional echocardiography.Six-Minute Walk Test as a Predictor of Diagnosis, Disease Severity, and Clinical Outcomes in Scleroderma-Associated Pulmonary Hypertension: The DIBOSA Study.Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012.The Importance of Echocardiographic Screening for Pulmonary Arterial Hypertension in Korean Patients with Systemic Sclerosis.
P2860
Q27021067-59BE1CE7-8128-44A6-A47D-092C2608F6FCQ30463476-4CDB4B3E-DAD2-4F3F-9AF9-919A1848A269Q30562538-E3AF9A76-F7E0-46BC-B5C2-239D24F4982DQ30990678-1FAF5CE1-D7C2-469B-B92D-7751DFBAD0ABQ33801248-BA95B30A-4D5D-47E3-B04F-94779EEC0260Q33834751-B6C909DD-21CD-477D-8827-C748F7E3781CQ34609902-0D9EC7EC-C82B-445B-A935-8872B2E9A44BQ34919733-25132B6D-E95B-43B0-883B-40609BA66557Q34987366-64557D7A-CA74-4227-9B58-D31BFAD27A97Q35029607-82C8150B-ADC5-477A-B155-9664F5C6878AQ35096375-625BC635-37FE-41B3-91CB-E6B8BDF0BFCEQ35759176-250B6ABC-48C4-44E7-B0E2-9C0AB814EAFDQ35923222-3D5B0953-082E-4E54-96E2-6E5FCCBCE344Q36060142-3379675B-8C1B-4B74-8EDF-C2E310F843E7Q37185564-234944E0-D585-492B-A72A-45D876ADB93BQ37233050-3BBD4D30-9362-4E93-A48B-AAB05506C19AQ37345940-E73E1F1C-853D-4930-B287-CEE73C226B6CQ37363859-86857A31-CC19-4D4F-94DA-591886E23362Q37555421-BCFCC560-AD76-4725-9A18-CE61B1DC3AADQ37585187-CFF8C07D-FC40-4E7E-BCA2-E684D0FF0133Q37686449-FB760305-76A5-4BFE-86AF-742E3C7F5A6DQ37690888-0C603C48-37DA-439C-98AF-A407E128360EQ38015787-32C5FE47-9BB0-4324-9A9B-DFF4ABB4EAC2Q38059459-0FFA95E4-E4BC-4B07-95E1-972CAC011A52Q38076680-06DBFDF3-9266-47CD-9CEE-FC5F54128021Q38101137-685724D1-FDF2-45B2-986D-3807CE24AB1FQ38112387-E63AFCF5-8B1B-483D-807F-C45894CDF4D0Q38135045-8D23307C-A8E7-4FB3-B68F-B87E5FA8BBE3Q38156227-5328A481-2BAC-46C9-8D49-6A3E003FAE19Q38204351-D48578EC-11C1-4639-BD07-0360048B87E2Q38271027-D5F48DB0-25B8-436B-82DA-DAB1DEDFC6E2Q38367248-7673C8E2-29BB-4E9D-B0C1-4310E3166EAEQ38630663-9B275AAC-010D-4D72-8180-5E14A4E577E4Q38721897-DC694160-44CC-454E-8C19-562FA3738972Q38771824-3AA6BFEC-6F75-4E22-B2BB-30AD43993000Q39138240-DF0EACDE-3284-4B9F-81C7-B6D8D2CED59CQ39313877-FB795527-89E8-4DEE-96E1-CC64D307FBD6Q39395367-BF322969-B55F-40D2-B235-BAD711AAD500Q40696023-7C2D7BC0-CCBC-4B8E-B69E-2CA3A3F0964AQ42330701-40C49597-3CEB-4C12-A301-E2B8A10D80A8
P2860
Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2011
@uk
name
Screening for pulmonary arteri ...... agnosis and long-term survival
@en
Screening for pulmonary arteri ...... agnosis and long-term survival
@nl
type
label
Screening for pulmonary arteri ...... agnosis and long-term survival
@en
Screening for pulmonary arteri ...... agnosis and long-term survival
@nl
prefLabel
Screening for pulmonary arteri ...... agnosis and long-term survival
@en
Screening for pulmonary arteri ...... agnosis and long-term survival
@nl
P2093
P2860
P50
P356
P1476
Screening for pulmonary arteri ...... agnosis and long-term survival
@en
P2093
Azzedine Yaici
Gérald Simonneau
Loïc Guillevin
Pierre Clerson
Virginie Gressin
P2860
P304
P356
10.1002/ART.30541
P577
2011-10-28T00:00:00Z